Clinical Trial: Symptom Trajectory Approaches to Research

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07804875) titled 'Symptom Trajectory Approaches to Research' on Sept. 01. Brief Summary: The goal of this ob... Read More

Singapore Clinical Trial: A single-ascending and multiple-ascending dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of LY4226695 in healthy participants.

Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A single-ascending and multiple-ascending dose study to evaluate the safety, tolerability, pharmac... Read More

Singapore Clinical Trial: An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembrolizumab Versus Chemotherapy in Subjects with Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma that Expresses HER2 (IHC 1+ and Greater)

Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembr... Read More

Singapore Clinical Trial: A Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of VRN110755 in Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)

Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Ef... Read More

Singapore Clinical Trial: A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Platinum-Based Chemotherapy ± Bevacizumab as 2L Treatment in Participants With Recurrent Platinum-Sensitive Ovarian Cancer

Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Pl... Read More

Singapore Clinical Trial: An Open-Label, Rollover Study for Participants with Thyroid Eye Disease Previously Enrolled in Amgen-Sponsored AMG 732 Studies and are Primary Proptosis Non-Responders or Who Relapsed During the Safety Follow-Up

Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'An Open-Label, Rollover Study for Participants with Thyroid Eye Disease Previously Enrolled in Amg... Read More

Clinical Trial: AI-Based Personalized Digital Management for High-Risk Pulmonary Nodule Follow-up

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07805434) titled 'AI-Based Personalized Digital Management for High-Risk Pulmonary Nodule Follow-up' on Sept.... Read More

Singapore Clinical Trial: An Open-Label Study to Investigate the Long-Term Effects of Acoramidis on Cardiac Function, Structure and Cardiac Amyloid Burden in Participants with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'An Open-Label Study to Investigate the Long-Term Effects of Acoramidis on Cardiac Function, Struct... Read More

Singapore Clinical Trial: A Phase 1, Open-Label, Randomized, Crossover Study to Investigate the Relative Bioavailability of Abemaciclib (LY2835219) Test and Reference Formulations and an Alternate Administration Method, in Healthy Participants

Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Open-Label, Randomized, Crossover Study to Investigate the Relative Bioavailability of ... Read More

Singapore Clinical Trial: Solid tumor Study for Long term Treatment of Cancer Patients Who Have Participated in BMS-Parent Studies Investigating Adagrasib (BMS-986503)

Singapore, Sept. 5 -- The Health Sciences Authority received information related to the study titled 'Solid tumor Study for Long term Treatment of Cancer Patients Who Have Participated in BMS-Parent S... Read More

• ««
• «
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• »
• »»